COVID-19 and the Ocular Surface: A Review of Transmission and Manifestations

References

• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.doi:10.1016/S0140-6736(20)30183-5.
   PubMed Web of Science ®Google Scholar
• Fu L, Wang B, Yuan T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis. J Infect. 2020;80(6):656–665.doi:10.1016/j.jinf.2020.03.041.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Infection prevention and controlduring healthcare when COVID-19 is suspected. https://www.who.int/publications-detail/infection-prevention-and-control-during-health-care-when-novel-coronavirus-(ncov)-infection-is-suspected-20200125. Published March 19, 2020.
   Google Scholar
• Loon S-C, Teoh SCB, Oon LLE, et al. The severe acute respiratory syndrome coronavirus in tears. Br J Ophthalmol. 2004;88(7):861–863.doi:10.1136/bjo.2003.035931.
   PubMed Web of Science ®Google Scholar
• van der Hoek L, Pyrc K, Jebbink MF, et al. Identification of a new human coronavirus. Nat Med. 2004;10(4):368–373.doi:10.1038/nm1024.
   PubMed Web of Science ®Google Scholar
• Vabret A, Mourez T, Dina J, et al. Human coronavirus NL63, France. Emerg Infect Dis. 2005;11(8):1225–1229.doi:10.3201/eid1108.050110.
   PubMed Web of Science ®Google Scholar
• Mackenzie JS, Smith DW. COVID-19: a novel zoonotic disease caused by a coronavirus from China: what we know and what we don’t. Microbiol Aust. 2020;MA20013. doi:10.1071/MA20013.
   PubMed Web of Science ®Google Scholar
• Guo Y-R, Cao Q-D, Hong Z-S, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020;7(1):11.doi:10.1186/s40779-020-00240-0.
   PubMed Web of Science ®Google Scholar
• Lu C-W, Liu X-F, Jia Z-F. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet. 2020;395(10224):e39. doi:10.1016/S0140-6736(20)30313-5.
   PubMed Web of Science ®Google Scholar
• Belser JA, Rota PA, Tumpey TM. Ocular tropism of respiratory viruses. Microbiol Mol Biol Rev. 2013;77(1):144–156. doi:10.1128/MMBR.00058-12.
   PubMed Web of Science ®Google Scholar
• Hu K, Patel J, Patel BC. Ophthalmic Manifestations Of Coronavirus (COVID-19). StatPearls, Treasure Island (FL): StatPearls Publishing; 2020.
   Google Scholar
• Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm. 2020;28(3):391–395. doi:10.1080/09273948.2020.1738501.
   PubMed Web of Science ®Google Scholar
• Sarma P, Kaur H, Kaur H, et al. Ocular manifestations and tear or conjunctival swab PCR positivity for 2019-nCoV in patients with COVID-19: A systematic review and meta-analysis. Lancet. 2020. doi:10.2139/ssrn.3566161.
   Google Scholar
• Holappa M, Vapaatalo H, Vaajanen A. Many faces of renin-angiotensin system - focus on eye. Open Ophthalmol J. 2017;11(1):122–142. doi:10.2174/1874364101711010122.
   PubMedGoogle Scholar
• Sun Y, Liu L, Pan X, Jing M. Mechanism of the action between the SARS-CoV S240 protein and the ACE2 receptor in eyes. Int J Ophthalmol Chi. 2006;6:783.
   Google Scholar
• Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020;92(6):589–594. doi:10.1002/jmv.25725.
   PubMed Web of Science ®Google Scholar
• Seah IYJ, Anderson DE, Kang AEZ, et al. Assessing viral shedding and infectivity of tears in coronavirus disease 2019 (COVID-19) patients. Ophthalmology. 2020. doi:10.1016/j.ophtha.2020.03.026.
   PubMed Web of Science ®Google Scholar
• Liang L, Wu P. There may be virus in conjunctival secretion of patients with COVID-19. Acta Ophthalmol. 2020;98(3):223. doi:10.1111/aos.14413.
   PubMed Web of Science ®Google Scholar
• Wu P, Duan F, Luo C, et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020;138(5):575.doi:10.1001/jamaophthalmol.2020.1291.
   PubMed Web of Science ®Google Scholar
• Lauer SA, Grantz KH, Bi Q, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020;172(9):577–582.doi:10.7326/M20-0504.
   PubMed Web of Science ®Google Scholar
• Deng C, Yang Y, Chen H, et al. Ocular Detection of SARS-CoV-2 in 114 cases of COVID-19 Pneumonia in Wuhan, China: an observational study. SSRN Electronic Journal. 2020. doi:10.2139/ssrn.3543587.
   Google Scholar
• Guan W-J, Ni Z-Y, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720.doi:10.1056/NEJMoa2002032.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zeng Y, Tong Y, Chen C. Ophthalmologic evidence against the interpersonal transmission of 2019 novel coronavirus through conjunctiva. MedRxiv. 2020. doi:10.1101/2020.02.11.20021956.
   Google Scholar
• Sun X, Zhang X, Chen X, et al. The infection evidence of SARS-COV-2 in ocular surface: a single-center cross-sectional study. MedRxiv. 2020. doi:10.1101/2020.02.26.20027938.
   Google Scholar
• Chen L, Deng C, Chen X, et al. Ocular manifestations and clinical characteristics of 534 cases of COVID-19 in China: a cross-sectional study. MedRxiv. 2020. doi:10.1101/2020.03.12.20034678.
   Google Scholar
• Zhou Y, Duan C, Zeng Y, et al. Ocular findings and proportion with conjunctival SARS-COV-2 in COVID-19 patients. Ophthalmology. 2020. doi:10.1016/j.ophtha.2020.04.028.
   Google Scholar
• Lescure F-X, Bouadma L, Nguyen D, et al. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis. 2020. doi:10.1016/S1473-3099(20)30200-0.
   PubMed Web of Science ®Google Scholar
• Scalinci SZ, Trovato Battagliola E. Conjunctivitis can be the only presenting sign and symptom of COVID-19. IDCases. 2020;20:e00774. doi:10.1016/j.idcr.2020.e00774.
   PubMed Web of Science ®Google Scholar
• Hong N, Yu W, Xia J, Shen Y, Yap M, Han W. Evaluation of ocular symptoms and tropism of SARS-CoV -2 in patients confirmed with COVID-19. Acta Ophthalmol. 2020;17:949. doi:10.1111/aos.14445.
   Google Scholar
• Chen L, Liu M, Zhang Z, et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br J Ophthalmol. 2020;bjophthalmol-2020-316304. doi:10.1136/bjophthalmol-2020-316304.
   Web of Science ®Google Scholar
• Colavita F, Lapa D, Carletti F, et al. SARS-CoV-2 isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection. Ann Intern Med. 2020. doi:10.7326/M20-1176.
   PubMed Web of Science ®Google Scholar
• Guillen E, Pineiro GJ, Revuelta I, et al. Case report of COVID-19 in a kidney transplant recipient: does immunosuppression alter the clinical presentation? Am J Transplant. 2020. doi:10.1111/ajt.15874.
   Google Scholar
• Cheema M, Aghazadeh H, Nazarali S, et al. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Can J Ophthalmol. 2020. doi:10.1016/j.jcjo.2020.03.003.
   PubMed Web of Science ®Google Scholar
• Salducci M, La Torre G. COVID-19 emergency in the cruise’s ship: a case report of conjunctivitis. Clin Ter. 2020;171(3):e189–91. doi:10.7417/CT.2020.2212.
   PubMed Web of Science ®Google Scholar
• Daruich A, Martin D, Bremond-Gignac D. Unilateral conjunctivitis as first presentation of coronavirus disease 2019 (COVID-19): A telemedicine diagnosis. J Fr Ophthalmol. 2020;43(5):389–391. doi:10.1016/j.jfo.2020.04.001.
   PubMed Web of Science ®Google Scholar
• Wu P, Liang L, Chen C, Nie S. A child confirmed COVID-19 with only symptoms of conjunctivitis and eyelid dermatitis. Graefes Arch Clin Exp Ophthalmol. 2020. doi:10.1007/s00417-020-04708-6.
   Web of Science ®Google Scholar
• Marinho PM, Marcos AAA, Romano AC, Nascimento H, Belfort R Jr. Retinal findings in patients with COVID-19. Lancet. 2020 May 12. [Epub ahead of print]. doi:10.1016/S0140-6736(20)31014-X. .
   Web of Science ®Google Scholar
• Gutiérrez-Ortiz C, Méndez A, Rodrigo-Rey S, et al. Miller fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020. doi:10.1212/WNL.0000000000009619.
   PubMed Web of Science ®Google Scholar
• Hearne BJ, Hearne EG, Montgomery H, Lightman SL. Eye care in the intensive care unit. Pediatr Crit Care Med. 2018;19(4):345–350. doi:10.1177/1751143718764529.
   PubMed Web of Science ®Google Scholar
• Klaassen-Broekema N, van Bijsterveld OP. Red eyes in renal failure. Br J Ophthalmol. 1992;76(5):268–271. doi:10.1136/bjo.76.5.268.
   PubMed Web of Science ®Google Scholar
• Glauser FL. Bilateral Chemosis and Conjunctival Venous Engorgement in Cardiopulmonary Failure. Chest. 1974;66(4):389–394. doi:10.1378/chest.66.4.389.
   PubMed Web of Science ®Google Scholar
• Oudkerk M, Büller HR, Kuijpers D, et al. Diagnosis, prevention, and treatment of thromboembolic complications in COVID-19: report of the National Institute for Public Health of the Netherlands. Radiology. 2020;201629. doi:10.1148/radiol.2020201629.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med. 2020;382(17):e38.doi:10.1056/NEJMc2007575.
   PubMed Web of Science ®Google Scholar
• Magro C, Justin Mulvey J, Berlin D, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Trans Res. 2020. doi:10.1016/j.trsl.2020.04.007.
   Google Scholar